The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) shares is ongoing concerning potential breaches of fiduciary duties by certain Galectin Therapeutics officers and directors. Investors who purchased shares of Galectin Therapeutics Inc. (NASDAQ:GALT) and currently hold any of those NASDAQ:GALT shares have certain […]
Long Term Investor Alert: Sarepta Therapeutics Inc (NASDAQ:SRPT) under Investigation
The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) was initiated concerning potential breaches of fiduciary duties by certain directors and officers of Sarepta Therapeutics Inc. Investors who are current long term investors in Sarepta Therapeutics Inc (NASDAQ:SRPT) shares, have certain options and should […]
Investor Alert: Lawsuit against Sarepta Therapeutics Inc (NASDAQ:SRPT) alleges Securities Law Violations
The Shareholders Foundation announces that an investor, who purchased shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Sarepta Therapeutics in connection with certain allegedly false and misleading statements made between April 21, 2014 and October 27, […]
Shocking Facts About Rape in the U.S.
A recent allegation of rape against a prominent New York lawyer went public this week as a letter from the victim was delivered to the Manhattan district attorney’s office. The letter demands that the accused attorney be arrested and charged with third-degree rape which allegedly occurred at the attorney’s Upper East Side apartment. The incident […]
Investor Alert: Galectin Therapeutics Inc. (NASDAQ:GALT) faces Investigation of potential Wrongdoing
The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) was launched concerning potential breaches of fiduciary duties by certain directors and officers. Investors who are current long term investors in Galectin Therapeutics Inc. (NASDAQ:GALT) shares, have certain options and should contact the Shareholders Foundation […]
Investor Alert: Deadline in Lawsuit against Galectin Therapeutics Inc. (NASDAQ:GALT) on September 29, 2014
The Shareholders Foundation announces that a deadline is coming up on September 29, 2014 in the lawsuit filed for investors of Galectin Therapeutics Inc. (NASDAQ:GALT) over alleged Violations of Federal Securities Laws by Galectin Therapeutics. Investors who purchased shares of Galectin Therapeutics Inc. (NASDAQ:GALT) have certain options and there are strict and short deadlines running. […]
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 38
- Next Page »